OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
17
Results
Show all
Save search
Copy query
Show results for
Unknown
(17)
Publication Date
Release Date
2024
(4)
2021
(2)
2012
(2)
2025
(1)
2023
(1)
2022
(1)
2020
(1)
2018
(1)
2017
(1)
2014
(1)
2013
(1)
2010
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
19p13 microduplications encompassing NFIX are responsible for intellectual disability, short stature and small head circumference.
Not available
S-EPMC5838975
|
biostudies-literature
Cite
Ultrarare heterozygous pathogenic variants of genes causing dominant forms of early-onset deafness underlie severe presbycusis.
Not available
S-EPMC7733833
|
biostudies-literature
Cite
Phenotypic spectrum and genomics of undiagnosed arthrogryposis multiplex congenita.
Not available
S-EPMC9132874
|
biostudies-literature
Cite
Pathogenic variants in KMT2C result in a neurodevelopmental disorder distinct from Kleefstra and Kabuki syndromes.
Not available
S-EPMC11339626
|
biostudies-literature
Cite
Episignatures in practice: independent evaluation of published episignatures for the molecular diagnostics of ten neurodevelopmental disorders.
Not available
S-EPMC10853222
|
biostudies-literature
Cite
Dominant variants in major spliceosome U4 and U5 small nuclear RNA genes cause neurodevelopmental disorders through splicing disruption.
Not available
S-EPMC12165858
|
biostudies-literature
Cite
Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial.
Not available
S-EPMC8015393
|
biostudies-literature
Cite
Systematic analysis of blood cell transcriptome in end-stage chronic respiratory diseases.
Not available
S-EPMC4203719
|
biostudies-literature
Cite
POSTER AWARD WINNER EDUCATION : SCI-U: AN INNOVATIVE APPROACH TO ONLINE PATIENT EDUCATION IN SPINAL CORD INJURY
Not available
S-EPMC3459571
|
biostudies-literature
Cite
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial.
Not available
S-EPMC8078879
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets